The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effects. - Groenink,L.; van der Gugten,J.; Verdouw,P.M.; Maes,R.A.; Olivier,B. (Eur J Pharmacol, 1995)